BerandaSDGR • NASDAQ
add
Schrodinger Inc
$20,84
Setelah Jam Perdagangan Normal:(1,25%)+0,26
$21,10
Tutup: 22 Nov, 20.00.00 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$20,37
Rentang hari
$20,08 - $21,21
Rentang tahun
$16,67 - $38,00
Kapitalisasi pasar
1,52 M USD
Volume Rata-Rata
806,26 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 35,29 jt | -17,10% |
Biaya operasional | 86,15 jt | 7,91% |
Laba bersih | -38,14 jt | 38,51% |
Margin laba bersih | -108,06 | 25,83% |
Penghasilan per saham | -0,87 | -24,29% |
EBITDA | -66,86 jt | -21,75% |
Tarif pajak efektif | 0,24% | — |
Neraca
Total aset
Total liabilitas
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 388,68 jt | -21,68% |
Total aset | 669,30 jt | -15,72% |
Total liabilitas | 219,87 jt | -4,64% |
Total ekuitas | 449,42 jt | — |
Saham yang beredar | 72,86 jt | — |
Harga terhadap nilai buku | 3,30 | — |
Tingkat pengembalian aset | -25,20% | — |
Tingkat pengembalian modal | -29,30% | — |
Arus Kas
Perubahan kas bersih
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | -38,14 jt | 38,51% |
Kas dari operasi | -33,26 jt | 33,41% |
Kas dari investasi | 90,70 jt | 587,00% |
Kas dari pembiayaan | 392,00 rb | -70,53% |
Perubahan kas bersih | 57,84 jt | 263,35% |
Arus kas bebas | -14,71 jt | 61,72% |
Tentang
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science.
Schrödinger's software is used by pharmaceutical companies, biotech firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market.
Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery. Wikipedia
CEO
Didirikan
1990
Situs
Karyawan
867